BUSINESS● LOW3h ago · Sep 29, 2026, 9:45 AM
AstraZeneca invests £1 . 5bn into US firm Summit for cancer drug tie - up
impartialreporter.com · United Kingdom · global
AstraZeneca is investing £1.5 billion into US firm Summit to collaborate on a cancer drug. This partnership aims to advance cancer treatment development between the two companies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited Kingdom and nearby eventsMore from United KingdomLatest stories and threat level
More from United Kingdom
MILITARY1h agoMystery in the United Kingdom after the release of suspects planning an attack on a military baseClarínPOLITICS1h agoThe united kingdom is acting with international partners to protect the two - state solution : united kingdom statement at the UN Security Councilglobalsecurity.org · SyriaPOLITICS1h agoWhat the united kingdom state pension triple lock is as it comes under scrutinyexpress.co.uk · United KingdomMILITARY4h agoMarco Rubio says suspected terror plot at united kingdom air base involved a foreign actor thejournal.ie · Ireland
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS29m agoPlug Power's shares rise on electrolyzer deal with Arcadia eFuelsSeeking Alpha TechBUSINESS31m agoStay informed with the moves of this September 29, 2026La Silla Vacía